WOCKPHARMA.NS Balance Sheet
Wockhardt Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:46
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹2,022.00 Cr. | ₹1,875.00 Cr. | ₹1,718.00 Cr. | ₹1,618.00 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹414.00 Cr. | ₹434.00 Cr. | ₹513.00 Cr. | ₹671.00 Cr. | CapitalWorkInProgress |
| Goodwill | ₹945.00 Cr. | ₹953.00 Cr. | ₹977.00 Cr. | ₹1,028.00 Cr. | Goodwill |
| Other Intangible Assets | ₹75.00 Cr. | ₹53.00 Cr. | ₹41.00 Cr. | ₹145.00 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹222.00 Cr. | ₹218.00 Cr. | ₹195.00 Cr. | ₹199.00 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹5,475.00 Cr. | ₹5,465.00 Cr. | ₹5,566.00 Cr. | ₹5,918.00 Cr. | NoncurrentAssets |
| Inventories | ₹658.00 Cr. | ₹640.00 Cr. | ₹725.00 Cr. | ₹887.00 Cr. | Inventories |
| Trade Receivables | ₹797.00 Cr. | ₹618.00 Cr. | ₹661.00 Cr. | ₹588.00 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹90.00 Cr. | ₹505.00 Cr. | ₹112.00 Cr. | ₹217.00 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹422.00 Cr. | ₹412.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹309.00 Cr. | ₹268.00 Cr. | ₹412.00 Cr. | ₹418.00 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹1,914.00 Cr. | ₹2,073.00 Cr. | ₹2,465.00 Cr. | ₹2,606.00 Cr. | CurrentAssets |
| Total Assets | ₹7,683.00 Cr. | ₹7,649.00 Cr. | ₹8,135.00 Cr. | ₹8,615.00 Cr. | Assets |
| Equity Share Capital | ₹72.00 Cr. | ₹77.00 Cr. | ₹81.00 Cr. | ₹81.00 Cr. | EquityShareCapital |
| Other Equity | ₹3,282.00 Cr. | ₹3,282.00 Cr. | ₹4,272.00 Cr. | ₹4,859.00 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹3,354.00 Cr. | ₹3,359.00 Cr. | ₹4,353.00 Cr. | ₹4,940.00 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹308.00 Cr. | ₹303.00 Cr. | ₹304.00 Cr. | ₹341.00 Cr. | NonControllingInterest |
| Total Equity | ₹3,662.00 Cr. | ₹3,662.00 Cr. | ₹4,657.00 Cr. | ₹5,281.00 Cr. | Equity |
| Long-term Borrowings | ₹224.00 Cr. | ₹891.00 Cr. | ₹1,211.00 Cr. | ₹1,518.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹586.00 Cr. | ₹1,196.00 Cr. | ₹1,436.00 Cr. | ₹1,712.00 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹1,663.00 Cr. | ₹1,221.00 Cr. | ₹648.00 Cr. | ₹607.00 Cr. | BorrowingsCurrent |
| Trade Payables | ₹867.00 Cr. | ₹766.00 Cr. | ₹592.00 Cr. | ₹563.00 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹126.00 Cr. | ₹163.00 Cr. | ₹238.00 Cr. | ₹203.00 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹3,435.00 Cr. | ₹2,791.00 Cr. | ₹2,042.00 Cr. | ₹1,622.00 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹7,683.00 Cr. | ₹7,649.00 Cr. | ₹8,135.00 Cr. | ₹8,615.00 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from WOCKPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).